642.e1

REFERENCES 1. Abdel-Hady H, Shouman B, Aly H: Early weaning from CPAP

to high flow nasal cannula in preterm infants is associated with prolonged oxygen requirement: a randomized controlled trial, Early Hum Dev 87:205, 2011.

2. Abdel-Latif ME, Osborn DA: Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome, Cochrane Database Syst Rev 7:CD008309, 2011.

3. Abdel-Latif ME, Osborn DA: Nebulized surfactant in preterm infants with or at risk of respiratory distress syndrome, Cochrane Database Syst Rev 10:CD008310, 2012.

4. Afjeh SA, Sabzehei MK, Karimi A, et al: Surveillance of ven-tilator-associated pneumonia in a neonatal intensive care unit: characteristics, risk factors, and outcome, Arch Iran Med 15:568, 2012.

5. Alexander N, Rosenlocher F, Stadler T, et al: Impact of ante-natal synthetic glucocorticoid exposure on endocrine stress re-activity in term-born children, J Clin Endocrinol Metab 97:3538, 2012.

6. Al-Saif S, Alvaro R, Manfreda J, et al: A randomized controlled trial of theophylline versus CO2 inhalation for treating apnea of prematurity, J Pediatr 153:513, 2008.

7. Aly H, Badawy M, El-Kholy A, et al: Randomized, controlled trial on tracheal colonization of ventilated infants: can grav-ity prevent ventilator-associated pneumonia? Pediatrics 122:770, 2008.

8. Aly H, Badawy M, Tomerak RH, et al: Tracheal colonization in preterm infants supported with nasal continuous positive airway pressure, Pediatr Int 54:356, 2012.

9. American Academy of Pediatrics, Committee on Fetus and Newborn: Respiratory support in preterm infants at birth, Pediatrics 133:171, 2014.

10. American Academy of Pediatrics and American College of Obstetricians and Gynecologists: Guidelines for perinatal care, ed 7, Elk Grove Village, Ill, 2012, American Academy of Pedi-atrics.

11. American Academy of Pediatrics and the Canadian Pediatrics Society: Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants, Pediatrics 117:1846, 2006.

12. American Academy of Pediatrics, Committee on Fetus and Newborn: Postnatal corticosteroids to prevent or treat bron-chopulmomary dysplasia, Pediatrics 126:800, 2010.

13. American Association for Respiratory Care: AARC Clini-cal practice guidelines: endotracheal suctioning of mechani-cally ventilated patients with artificial airways, 2010, Respir Care 55:758, 2010.

14. American College of Obstetricians and Gynecologists: Commit-tee on Obstetric Practice: ACOG Committee Opinion #475. Antenatal corticosteroid therapy for fetal maturation, Obstet Gy-necol 177:422, 2011.

15. Askie LM, Ballard RA, Cutler GR, et al: Meta-analysis of preterm patients on inhaled nitric oxide collaboration: an individual- patient data meta-analysis of randomized trials, Pediatrics 128:729, 2011.

16. Askie L, Brocklehurst P, Darlow BA, et al: NeOProM: Neona-tal Oxygenation Prospective Meta-analysis Collaboration Study protocol, BMC Pediatr 11:6, 2011.

17. Deleted in pages. 18. Askie L, Henderson-Smart D, Irwing L, et al: Oxygen saturation

targets and outcomes in extremely preterm infants, N Engl J Med 349:959, 2003.

19. Atsay B, Ergun H, Okulu E, et al: The association between cord hormones and transient tachypnea of the newborn in late pre-term and term neonates who are delivered by cesarean section, J Matern Fetal Neonatal Med 26:877, 2013.

20. Avery ME, Tooley WH, Keller JB, et al: Is chronic lung disease in low birth weight infants preventable? A survey of eight centers, Pediatrics 79:26, 1987.

21. Aziz H, Martin J, Moore J: The pediatric disposable end-tidal carbon dioxide detector role in endotracheal intubation in new-borns, J Perinatol 19:110, 1999.

22. Baba L, McGrath J: Oxygen free radicals: effects in the newborn period, Adv Neonatal Care 8:256, 2008.

23. Badr MA, Ali YF, Albanna EA, et al: Ventilator associated pneu-monia in critically ill neonates admitted to neonatal intensive care unit, Zagazig university hospitals, Iran J Pediatr 21:418, 2011.

24. Bagley CE, Gray PH, Tudehope DI, et al: Routine postextuba-tion chest physiotherapy: a randomized controlled trial, J Paediatr Child Health 41:592, 2005.

25. Bahman-Bijari B, Malekiyan A, Niknafs P, Baneshi MR: Bubble -CPAP vs. ventilatory-CPAP in preterm infants with respiratory distress, Iran J Pediatr 21:151, 2011.

26. Bak SY, Shin YH, Jeon JH, et al: Prognostic factors for treat-ment outcomes in transient tachypnea of the newborn, Pediatr Int 54:875, 2012.

27. Ballabh P, Kumari J, Krauss A, et al: Soluble E-selectin, soluble L-selectin and soluble ICAM-1 in bronchopulmonary dysplasia, and changes with dexamethasone, Pediatrics 111:461, 2003.

28. Ballard P, Truog W, Merrill J, et al: Plasma biomarkers of oxida-tive stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants, Pediatrics 121:555, 2008.

29. Bancalari E, Claure N: The evidence for non-invasive ventilation in the preterm infant, Arch Dis Child Fetal Neonatal Ed 98:F98, 2013.

30. Baquero H, Soliz A, Neira F, et al: Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot ran-domized blinded study, Pediatrics 117:1077, 2006.

31. Barbarosa AL, Cardoso MV, Brasil TB, Scochi CG: Endotracheal and upper airways suctioning: changes in newborns’ physiologi-cal parameters, Rev Lat Am Enfermagem 19:1369, 2011.

32. Barrington K: Hazards of systemic steroids for ventilator- dependent preterm infants: what would the parents want? J Can Med Assoc 165:33, 2001.

33. Barrington K: The adverse neurodevelopmental effects of post-natal steroids in the preterm infant: a systematic review of RCTs, BMC Pediatr 1:1, 2001.

34. Barrington K, Bull D, Finer N: Randomized trial of nasal syn-chronized intermittent mandatory ventilation compared with continuous positive airway pressure after extubation of very low birth weight infants, Pediatrics 107:638, 2001.

35. Barrington K, Finer N: Inhaled nitric oxide for respiratory fail-ure in preterm infants, Cochrane Database Syst Rev 3:CD000509, 2010.

36. Baumer J: International randomized controlled trial of patient triggered ventilation in neonatal respiratory distress syndrome, Arch Dis Child Fetal Neonatal Ed 82:F5, 2000.

36a. Beardsmore CS, Westaway J, Killer H, et al: How does the chang-ing profile of infants who are referred for extracorporeal mem-brane oxygenation affect their overall respiratory outcome? Pedi-atrics 120:e762, 2007.

37. Beck J, Reilly M, Grasselli G, et al: Patient ventilator interaction during neutrally adjusted ventilator assists in low birth weight infants, Pediatr Res 65:663, 2009.

642.e2 References

38. Beligere N, Roa R: Neurodevelopmental outcome of infants with meconium aspiration syndrome: report of a study and lit-erature review, J Perinatol 28(suppl 3):S93, 2008.

39. Bell E, Acarregui M: Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants, Cochrane Database Syst Rev 1:CD000503, 2008.

40. Benders MJ, Groenendaal F, Van Bel F, et al: Brain development of the preterm neonate after neonatal hydrocortisone treatment for chronic lung disease, Pediatr Res 66:555, 2009.

41. Bennett NJ, Tabarani CM, Bartholoma NM, et al: Unrecognized viral respiratory tract infections in premature infants during their birth hospitalization: a prospective surveillance study in two neo-natal intensive care units, J Pediatr 161:814, 2012.

42. Ben Said M, Hays S, Loys CM, et al: Postnatal steroids in extremely low birth weight infants: betamethasone or hydrocor-tisone? Acta Paediatr 102:689, 2013.

43. Benson F, Cilander OC, Haglund G, et al: Positive pressure res-pirator treatment of severe pulmonary insufficiency in the new-born infant: a clinical report, Acta Anaesth Scand 2:37, 1958.

44. Beresford MW, Shaw NJ, Manning D: Randomised controlled trial of patient triggered and conventional fast rate ventilation in neonatal respiratory distress syndrome, Arch Dis Child Fetal Neonatal Ed 82:F14, 2000.

45. Bernstein G, Mannino F, Heldt G, et al: Randomized multi-center trial comparing synchronized and conventional intermit-tent mandatory ventilation (SIMV vs. IMV) in neonates, J Pediatr 128:4, 1996.

46. Bhandari A, Schramm CM, Kimble C, et al: Effect of a short course of prednisolone in infants with oxygen-dependent bron-chopulmonary dysplasia, Pediatrics 121:e344, 2008.

47. Bhandari V, Gavino RG, Nedrelow JH, et al: A randomized con-trolled trial of synchronized nasal intermittent positive pressure ventilation in respiratory distress syndrome, J Perinatol 27:697, 2007.

48. Bhat RY, Rafferty GF, Hannam S, et al: Acid gastroesophageal reflux in convalescent preterm infants: effects of posture and re-lationship to apnea, Pediatric Res 62:620, 2007.

49. Bhutani VK: Developing a systems approach to prevent meco-nium aspiration syndrome: lessons learned from multinational studies, J Perinatol 28:S30, 2008.

50. Birnkrant DJ, Picone C, Markowitz W, et al: Association of tran-sient tachypnea of the newborn and childhood asthma, Pediatr Pulmonol 41:978, 2006.

51. Bonsante F, Latorre G, Iacobelli S, et al: Early low-dose hydro-cortisone in very preterm infants: a randomized, placebo-con-trolled trial, Neonatology 91:217, 2007.

52. BOOST II United Kingdom Collaborative group, BOOST II Australia Collaborative group, BOOST II New Zealand Collab-orative group, et al: Oxygen saturation and outcomes in preterm infants, N Engl J Med 368:2094, 2013.

53. Boros SJ, Matalon SV, Ewald R, et al: The effect of independent variations in inspiratory-expiratory ratio and end expiratory pres-sure during mechanical ventilation in hyaline membrane disease: the significance of mean airway pressure, J Pediatr 91:114, 1977.

54. Deleted. 55. Brion L, Primhak R, Yong W: Aerosolised diuretics for preterm

infants with (or developing) chronic lung disease, Cochrane Data-base Syst Rev 3:CD001694, 2006.

56. Breatnach C, Conlon NP, Stack M, et al: A prospective crossover comparison of neutrally adjusted ventilator assist and pressure-support ventilation in a pediatric and neonatal intensive care unit population, Pediatr Crit Care Med 11:7, 2010.

57. Buckmaster AG, Arnolda G, Wright IM, et al: Continuous posi-tive airway pressure therapy for infants with respiratory distress in non-tertiary care centers: a randomized, controlled trial, Pedi-atrics 120:509, 2007.

58. Buzzella B, Claure N, D’Ugard C, Bamcalari E: A randomized controlled trial of two nasal continuous positive airway pressure levels after extubation in preterm infants, J Pediatr 164:46, 2014.

59. Campbell DM, Shah PS, Shah V, et al: Nasal continuous positive airway pressure from high flow cannula versus infant flow for preterm infants, J Perinatol 26:546, 2006.

60. Carlo WA: Gentle ventilation: the new evidence from the SUPPORT, COIN, VON, CURPAP, Colombian Network, and Neocosur Network trials, Early Hum Dev 88(suppl 2):S81, 2012.

61. Carlo WA, McDonald SA, Fanaroff AA, et al., and the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Association of ante-natal steroids with mortality and neurodevelopmnetal outcomes among infants born at 22-25 weeks’gestation, J Am Med Assoc 306:2348, 2011.

62. Carlo WA, Stark A, Wright L, et al: Minimal ventilation to prevent BPD in extremely-low-birth-weight infants, J Pediatr 141:370, 2002.

63. Cederqvist K, Haglund C, Heikkila P, et al: Pulmonary trypsin-2 in the development of bronchopulmonary dysplasia in preterm infants, Pediatrics 112:570, 2003.

64. Cernada M, Aguar M, Brugada M, et al: Ventilator-associated pneumonia in newborn infants diagnosed with an invasive bron-choalveolar lavage technique: a prospective observational study, Pediatr Crit Care Med 14:55, 2013.

65. Cernada M, Brugada M, Golombek S, Vento M: Ventilator- associated pneumonia in neonatal patients: an update, Neonatol-ogy 105:98, 2014.

66. Chawla S, Bapat R, Pappas A, et al: Neurodevelopmental out-come of extremely premature infants exposed to incomplete, no or complete antenatal steroids, J Matern Fetal Neonatal Med 26:1542, 2013.

67. Chawla S, Lua J, Natarajan G, et al: Postnatal respiratory compli-ance among premature ventilated neonates associated with vari-able timing and dosing of antenatal steroids, Am J Perinatol, April 4, 2014. E-pub ahead of print.

68. Chen IL, Ou-Yang MC, Chen FS, et al: High aspartate ami-notransferase level predicts poor neurodevelopmental outcome in infants witn mecomium aspiration syndrome, Am J Perinatol, December 17, 2013. E-pub ahead of print.

69. Cheong JL, Burnett AC, Lee KJ, the Victorian Infant Collabo-rative Study Group, et al: Association between postnatal dexa-methasone for treatment of bronchopulmonary dysplasia and brain volumes at adolescence in infants born very preterm, J Pediatr 164:737, 2014.

70. Chin S, Brodsky N, Bhandari V: Antenatal steroid use is asso-ciated with increased gastroesophageal reflux in neonates, Am J Perinatol 20:205, 2003.

71. Choi CW, Kim BI, Koh YY, et al: Clinical characteristics of chronic lung disease without preceeding respiratory distress syn-drome in preterm infants, Pediatr Int 47:72, 2005.

72. Choi HJ, Hahn S, Lee J, et al: Surfactant lavage therapy for meco-nium aspiration syndrome: a systematic review and meta-analy-sis, Neonatology 101:183, 2012.

73. Cignacco E, Humers JP, van Lingen RN, et al: Pain relief in ven-tilated preterms during endotracheal suctioning: a randomized controlled trial, Swiss Med Weekly 138:635, 2008.

642.e3References

74. Clark EA, Mele L, Wapner RJ, et al: Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network: Repeated course an-tenatal steroids, inflammation gene polymorphisms, and neurode-velopmental outcomes at age 2, Am J Obstet Gynecol 205:79, 2011.

75. Clark R, Gerstmann D, Jobe A, et al: Lung injury in neonates: causes, strategies for prevention, and long-term consequences, J Pediatr 139:478, 2001.

76. Clark R, Huckaby J, Kueser T, et al: Low-dose nitric oxide ther-apy for PPHN: 1-year follow-up, J Perinatol 23:300, 2003.

77. Clark R, Powers R, White R, et al: Prevention and treatment of nosocomial sepsis in the NICU, J Perinatol 24:446, 2004.

78. Clark R, Yoder B, Sell M: Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation, J Pediatr 124:447, 1994.

78a. Clark RH, Kueser TJ, Walker MW, et al: Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn, N Engl J Med 342:469, 2000.

79. Coates EW, Klinepeter ME, O’Shea TM: Neonatal pulmo-nary hypertension treated with inhaled nitric oxide and high- frequency ventilation, J Perinatol 28:675, 2008.

80. Cole FS, Alleyne C, Barks JD, et al: NIH Consensus Develop-ment Conference statement: inhaled nitric-oxide therapy for premature infants, Pediatrics 27:363, 2011.

81. Collins CL, Barfield C, Horne RS, Davis PG: A comparison of nasal trauma in preterm infants extubated to either heated hu-midified high-flow nasal cannulae or nasal continuous positive airway pressure, Eur J Pediatr 173:181, 2014.

82. Collins CL, Holberton JR, Barfield C, Davis PG: A randomized controlled trial to compare heated humidified high-flow nasal cannulae with nasal continuous positive airway pressure postex-tubation in premature infants, J Pediatr 162:949, 2013.

83. Collins CL, Holberton JR, Konig K: Comparison of the pharyngeal pressure provided by two heated, humidified high-flow nasal cannu-lae devices in premature infants, J Paediatr Child Health 49:554, 2013.

84. Colnaghi M, Condo V, Pugni L, et al: Endogenous nitric oxide production in the airways of preterm and term infants, Biol Neo-nate 83:113, 2003.

85. Cone S, Pickler RH, Grap MJ, et al: Endotracheal suctioning in preterm infants using four-handed versus routine care, J Obstet Gynecol Neonatal Nurse 42:92, 2013.

86. Coney S: Physiotherapy technique banned in Auckland, Lancet 345:510, 1995.

87. Deleted in pages. 88. Cools F, Askie LM, Offringa M, et al: Elective high-frequency

oscillatory versus conventional mechanical ventilation in pre-term infants: a systematic review and meta-analysis of individual patients’ data, Lancet 375:2082, 2010.

89. Cools F, Offringa M, Askie LM: Elective high-frequency oscilla-tory ventilation versus conventional ventilation for acute pulmo-nary dysfunction in preterm infants, Cochrane Database Syst Rev 3:CD000104, 2013.

90. Copetti R, Cattarossi L: The “double lung point”: an ultrasound sign diagnostic of transient tachypnea of the newborn, Neonatol-ogy 91:203, 2007.

91. Cordero L, Sananes M, Ayers L: Comparison of a closed (Trach Care MAC) with an open endotracheal suction system in small premature infants, J Perinatol 3:151, 2000.

92. Cordero L, Sananes M, Ayers L: A comparison of two airway suctioning frequencies in mechanically ventilated, very-low-birthweight infants, Respir Care 46:783, 2001.

93. Costa S, Rocha G, Leitao A, Guimaraes H: Transeint tachypnea of the newborn and congenital pneumonia: a comparative study, J Matern Fetal Neonatal Med 25:992, 2012.

94. Courtney S, Aghai Z, Saslow J, et al: Changes in lung volume and work of breathing: a comparison of variable-flow nasal continuous positive airway pressure devices in low birth weight infants, Pediatr Pulmonol 36:248, 2003.

95. Cox C, Wolfson M, Shafer T: Liquid ventilation: a comprehensive overview, Neonatal Netw 15:31, 1996.

96. Cross JH, Harrison CJ, Preston PR, et al: Postnatal encephalo-clastic porencephaly: a new lesion? Arch Dis Child 67:307, 1992.

97. Curtis P: Hyaline membrane disease, J Pediatr 51:726, 1957. 98. Dangeman BC, et al: The variability of PaO2 in newborn infants

in response to routine care, Pediatr Res 10:149, 1976. 99. D’Angio CT, Chess PR, Kovacs SJ, et al: Pressure regulated vol-

ume control ventilation vs. synchronized intermittent manda-tory ventilation for very-low-birth weight infants, Arch Pediatr Adolesc Med 159:868, 2005.

100. Dani C, Bertini G, Pezzati M, et al: Effects of pressure support ventilation plus volume guarantee vs. high frequency oscillatory ventilation on lung inflammation in preterm infants, Pediatr Pul-monol 41:242, 2006.

101. Dargaville PA: Respiratory support in meconium aspiration syn-drome: a practical guide, Int J Pediatr 2012:965159, 2012.

102. Dargaville PA: Innovation in surfactant therapy, I: surfactant lav-age and surfactant administration by fluid bolus using minimally invasive techniques, Neonatology 101:326, 2012.

103. Dargaville PA, Aiyappan A, DePaoli AG, et al: Minimally invasive surfactant in preterm infants on continuous positive airway pres-sure, Arch Dis Child Fetal Neonatal Ed 98:F122, 2013.

104. Dargaville PA, Copnell B, Mills JF, et al., and the less MAS Trial Study Group. Randomized controlled trial of lung lavage with dilute surfactant for meconium aspiration syndrome, J Pediatr 158:383, 2011.

105. Dargaville PA, Copnell B, Mills JF, and the less MAS Trial Study Group, et al: Fluid recovery during lung lavage in meconium aspiration syndrome, Acta Paediatr 102:e90, 2013.

106. Darlow B, Graham P: Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth-weight infants, Cochrane Database Syst Rev 10:CD000501, 2011.

107. Davis J, Parad R, Michele T, et al: Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recom-binant human CuZn Superoxide Dismutase, Pediatrics 111:469, 2003.

108. Davis JM, Bhutani VK, Stefano JL, et al: Changes in pulmonary mechanics following caffeine administration in infants with bronchopulmonary dysplasia, Pediatr Pulmonol 6:49, 1989.

109. Davis P, Henderson-Smart D: Extubation from low rate inter-mittent positive airways pressure vs. extubation after a trial of endotracheal CPAP in intubated preterm infants, Cochrane Database Syst Rev 4:CD001078, 2001.

110. Davis P, Henderson-Smart D: Nasal continuous positive airways pressure immediately after extubation for preventing morbid-ity in preterm infants, Cochrane Database Syst Rev 2:CD000143, 2003.

111. Davis PG, Morley CJ, Owen LS: Non-invasive respiratory sup-port of preterm neonates with respiratory distress: continuous positive airway pressure and nasal intermittent positive pressure ventilation, Semin Fetal Neonatal Med 14:14, 2009.

112. Davis PG, Schmidt B, Roberts RS, et al: Caffeine for apnea of prematurity trial: benefits may vary in subgroups, J Pediatr 156:382, 2010.

642.e4 References

113. DeBoer S, Seaver M: End tidal CO2 verification of endotracheal tube placement in neonates, Neonatal Netw 23:29, 2004.

114. Demirel G, Uras N, Celik IH, et al: Nasal intermittent manda-tory ventilation versus nasal continuous positive airway pressure for transient tachypnea of newborn: a randomized, prospective study, J Matern Fetal Neonatal Med 26:1099, 2013.

115. DePaoli A, Davis P, Faber B, et al: Devices and pressure sources for administration of nasal continuous positive airway pres-sure (NCPAP) in preterm neonates, Cochrane Database Syst Rev 4:CD002977, 2008.

116. DePaoli A, Davis P, Lemyre B: Nasal continuous positive airway pressure vs. nasal intermittent positive pressure ventilation for preterm neonates: a systematic review and meta-analysis, Acta Paediatr 92:70, 2003.

117. Derbent A, Tatli MM, Duran M, et al: Transient tachypnea of the newborn: effects of labor and delivery type in term and preterm pregnancies, Arch Gynecol Obstet 283:947, 2011.

118. DiFiore J, Arko M, Whitehouse M, et al: Apnea is not prolonged by acid gastroesophageal reflux (GER) in preterm infants, Pediat-rics 116:1059, 2005.

119. DiFiore JM, Walsh M, Wrage L, et al., and the SUPPORT study group: Low oxygen saturation target range is associated with in-creased incidence of intermittent hypoxia, J Pediatr 161:1047, 2012.

120. Donn S, Sinha S: Invasive and noninvasive neonatal mechanical ventilation, Respir Care 48:426, 2003.

121. Donohue PK, Gilmore MM, Cristofalo E, et al: Inhaled nitric oxide in preterm infants: a systematic review, Pediatrics 127:e414, 2011.

122. Doyle LW, Davis PG, Morley CJ, et al., Low-dose dexametha-sone facilitates extubation among chronically ventilator-depend-ent infants: a multicenter, international, randomized, controlled trial, Pediatrics 117:75, 2006.

123. Doyle LW, Davis PG, Morley CJ, et al: and the DART Study In-vestigators. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone, Pediatrics 119:716, 2007.

124. Doyle LW, Ehrenkranz RA, Halliday HL: Postnatal hydrocorti-sone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematuic review, Neonatology 98:111, 2010.

125. Doyle LW, Ehrenkranz RA, Halliday HL: Early (<8 days) corti-costeroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev 5:CD001146, 2014.

126. Doyle LW, Ehrenkranz RA, Halliday HL: Late (>7 days) corti-costeroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev 5:CD001145, 2014.

127. Duman N, Tuzun F, Sutcuoglu S, et al: Impact of volume guaran-tee on synchronized ventilation in preterm infants: a randomized controlled trial, Intensive Care Med 38:1358, 2012.

128. Dumas DeLa Roque E, Bertrand C, Tandonnet O, et al: Nasal high frequency percussive ventilation versus nasal continuous positive airway prtessure in transient tachypnea of the newborn: a pilot randomized controlled trial (NCT00556738), Pediatr Pul-monol 46:218, 2011.

129. Dunn MS, Kaempf J, deKlerk A, et al: Vermont Oxford Network Delivery Room Management Study Group: Randomized trial comparing 3 approaches to the initial respiratory management of preterm infants, Pediatrics 128:e1069, 2011.

130. Durrmeyer X, Hummler H, Sanchez-Luns M, and the European Union Nitric Oxide Study Group, et al: Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants, Pediatrics 132:e695, 2013.

131. Edtaki M, Puorpulad H, Kargar M, et al: Olfactory stimulation by vanillin prevents apnea in premature newborn infants, Iran J Pediatr 23:261, 2013.

132. Ehrenkranz RA, Walsh MC, Vohr BR, et al: National Institutes of Child Health and Human Development Neonatal Re-search Network: Validation of the National Institues of Health consensus definition of bronchopulmonary dysplasia, Pediatrics 116:1353, 2005.

133. Eichenwald E, Abimbola A, Stark A: Apnea frequently persists beyond term gestation in infants delivered at 24-28 weeks, Pedi-atrics 100:354, 1997.

134. Ekekezie II, Thibeault DW, Simon SD, et al: Low levels of tis-sue inhibitors of metalloproteinases with a high matrix metal-loproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease, Pediatrics 113:1709, 2004.

135. El-Ferzil GT, Dreher M, Patel RP, Ambalavanan N: ABO blood group is associated with response to inhaled nitric oxide in neo-nates with respiratory failure, PLoS One 7:e45164, 2012.

136. El Shahed AI, Dargaville P, Ohlsson A, et al: Surfactant for meconium aspiration syndrome in full term/near term infants, Cochrane Database Syst Rev 3:CD002054, 2007.

137. Eriksen V, Nielsen LH, Klokker M, et al: Follow-up of 5- to 11-year-old children treated for persistent pulmonary hyperten-sion of the newborn, Acta Paediatr 98:304, 2009.

138. Evans J: Incidence of hypoxia associated with caregiving in pre-mature infants, Neonatal Netw 10:17, 1991.

139. Evans J: Reducing the hypoxemia, bradycardia and apnea associ-ated with suctioning in low birthweight infants, J Perinatol 7:137, 1992.

140. Extracorporeal Life Support Organization: Neonatal ECMO registry: neonatal selection criteria. Available at www.med.umichedu/ecmo/physicians/neonatal. Accessed June 9, 2014.

141. Farrow KN, Steinhorn RH: Sildenafil therapy for bronchopul-monary dysplasia: not quite yet, J Perinatol 32:1, 2012.

142. Finer N, Barrington K: Nitric oxide for respiratory failure in infants born at or near term, Cochrane Database Syst Rev 4: CD000399, 2006.

143. Finer N, Craft A, Vaucher Y, et al: Postnatal steroids: short-term gain, long term pain? J Pediatr 137:9, 2000.

144. Finer NN, Mannino FL: High-flow cannula: a kinder, gentler CPAP? J Pediatr 154:160, 2009.

145. Firme S, McEvoy C, Alconcel C, et al: Episodes of hypoxemia during synchronized intermittent mandatory ventilation in ventilator-dependent very low birth weight infants, Pediatr Pulmonol 40:9, 2005.

146. Fischer C, Rybakowski C, Ferdynus C, et al: A population-based study of meconium aspiration syndrome in neonates born be-tween 37 and 43 weeks of gestation, Int J Pediatr 2012:321545, 2012.

147. Fischer HS, Buhrer C: Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis, Pediatrics 132:e1351, 2013.

148. Friedman CA, Menchaca RC, Baker MC, et al: Bubble nasal CPAP, early surfactant treatment, and rapid extubation associ-ated with decreased incidence of bronchopulmonary dysplasia in very-low-birth-weight newborns: efficacy and safety considera-tions, Respir Care 58:1134, 2013.

149. Gadhia MM, Cutter GR, Abman SH, Kinsella JP: Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure, J Pediatr 164:744, 2014.

642.e5References

150. Garland J, Nelson D, Rice T, et al: Increased risk of gastrointesti-nal perforations in neonates mechanically ventilated with either face mask or nasal prongs, Pediatrics 76:406, 1985.

151. Geary C, Caskey M, Fonseca R, et al: Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pres-sure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study, Pediat-rics 121:89, 2008.

152. Gelfand S, Fanaroff J, Walsh M: Controversies in the treatment of meconium aspiration syndrome, Clin Perinatol 31:445, 2004.

153. Gillespie LM, White SD, Sinha SK, et al: Usefulness of the min-ute ventilation test in predicting successful extubation in new-born infants: a randomized controlled trial, J Perinatol 23:205, 2003.

154. Gillies D, Spence K: Deep versus shallow suction of endotracheal tubes in ventilated neonates and young infants, Cochrane Database Syst Rev 7:CD003309, 2011.

155. Gitto E, Pellegrino S, Aversa S, et al: Oxidative stress and persis-temt pulmonary hypertension of the newborn treated with in-haled nitric oxide and different oxygen concentrations, J Matern Fetal Neonatal Med 25:1723, 2012.

156. Gizzi C, Papoff P, Campelli M, et al: Surfactant and non- invasive ventilation for preterm infants, Acta Biomed 83(suppl 1):24, 2012.

157. Gluck L, Kulovich M: Fetal lung development, Pediatr Clin North Am 20:367, 1973.

158. Gonzalez A, Fabres J, D’Apreemont I, et al: Randomized con-trolled trial of early compared with delayed use of inhaled nitric oxide in newborns with moderate respiratory failure and pulmo-nary hypertension, J Perinatol 30:420, 2010.

159. Gopel W, Kribs A, Ziegler A, and the German Neonatal Net-work, et al: Avoidance of mechanical ventilation by surfactant treatment in spontaneously breathing preterm infants (AMV): an open-label, randomized, controlled trial, Lancet 378:1627, 2011.

160. Gordon P, Rutledge J, Sawin R, et al: Early postnatal dexa-methasone increases the risk of focal small bowel perforation in extremely low birth weight infants, J Perinatol 19:573, 1999.

161. Gover A, Brummelte S, Synnes AR, et al: Single dose of antenatal steroids did not alter cortisol in preterm infants up to 18 months, Acta Paediatr 101:604, 2012.

162. Greenspan J, Wolfson M, Shaffer T: Liquid ventilation, Semin Perinatol 24:396, 2000.

163. Greenspan JS, Shaffer TH: Ventilator-induced airway injury: a critical consideration during mechanical ventilation of the in-fant, Neonatal Netw 25:159, 2006.

164. Gregory G: Respiratory care of newborn infants, Pediatr Clin North Am 19:311, 1972.

165. Greisen G, Frederiksen P, Hertel J, et al: Catecholamine response to chest physiotherapy and endotracheal suctioning in preterm infants, Acta Paediatr Scand 74:525, 1985.

166. Gupta P, Green JW, Tang X, et al: Comparison of high-frequen-cy oscillatory ventilation and conventional mechanical ventila-tion in pediatric respiratory failure, JAMA Pediatr 168:243, 2014.

167. Gupta S, Sinha SK, Donn SM: The effect of two levels of pressure support ventilation on tidal volume delivery and minute ventila-tion, Arch Dis Child Fetal Neonatal Ed 94:F80, 2009.

168. Gupta S, Sinha SK, Tin W, et al: A randomized controlled trial of post-extubation bubble continuous positive airway pressure versus Infant Flow Driver continuous positive airway pressure in preterm infants with respiratory distress syndrome, J Pediatr 154:645, 2009.

169. Guthrie SO, Lynn C, Lafleur BJ, et al: A crossover analysis of man-datory minute ventilation compared to synchronized intermittent mandatory ventilation in neonates, J Perinatol 25:643, 2005.

170. Guven S, Bozdag S, Saner H, et al: Early neonatal outcomes of volume guaranteed ventilation in preterm infants with respira-tory distress syndrome, J Matern Fetal Neonatal Med 26:396, 2013.

171. Hagadorn JI, Furey AM, Nghiem TH, et al: Achieved versus in-tended pulse oximeter saturation in infants born less than 28 weeks’ gestation: the AVIOx study, Pediatrics 118:1574, 2006.

172. Hahn S, Choi HJ, Soll R, Dargaville PA: Lung lavage for meco-nium aspiration syndrome in newborn infants, Cochrane Database Syst Rev 4:CD003486, 2013.

173. Hallenberger A, Poets CF, Horn W, et al: Closed-loop automatic oxygen control in preterm infants: a randomized controlled trial, Pediatrics 133:e379, 2014.

174. Hameed NN, Abdul-Jaleel RK, Saugstad OD: The use of con-tinuous positive airway pressure in preterm babies with respira-tory distress syndrome: a report from Baghdad, Iraq, J Matern Fetal Neonatal Med 27:629, 2014.

175. Harding JE, Miles FK, Becroft DM, et al: Chest physiotherapy may be associated with brain damage in extremely premature infants, J Pediatr 132:440, 1998.

176. Harrison H: Preemies on steroids: a new iatrogenic disaster? Birth 28:57, 2001.

177. Harrison VC, Heese H, Klein M: The significance of grunting in hyaline membrane disease, Pediatrics 41:549, 1968.

178. Henderson-Smart D, Davis P: Prophylactic methylxanthines for extubation in preterm infants, Cochrane Database Syst Rev 12:CD000139, 2010.

179. Henderson-Smart DJ, DePaoli AG, Clark RH, Bhuta T: High frequency oscillatory ventilation versus conventional mechanical ventilation for infants with severe pulmonary dysfunction born at or near term, Cochrane Database Syst Rev 3:CD002974, 2009.

180. Henderson-Smart DJ, Hutchinson JL, Donoghue DA, et al: Pre-natal predictors of chronic lung disease in very preterm infants, Arch Dis Child Fetal Neonatal Ed 91:F40, 2006.

181. Henderson-Smart D, Osborn D: Kinesthetic stimulation for preventing apnea in preterm infants, Cochrane Database Syst Rev 2:CD000373, 2002.

182. Henderson-Smart D, Steer P: Prophylactic methylxanthine for prevention of apnea in preterm infants, Cochrane Database Syst Rev 12:CD000432, 2010.

183. Henderson-Smart D, Steer P: Caffeine versus theophylline for apnea of prematurity, Cochrane Database Syst Rev 1:CD000273, 2010.

184. Hernandez-Diaz S, Van Marter LJ, Werler MM, et al: Risk factors for persistent pulmonary hypertension of the newborn, Pediatrics 120:e272, 2007.

185. Herrera C, Gerhardt T, Claure N, et al: Effects of volume-guaranteed synchronized intermittent mandatory ventilation in preterm infants recovering from respiratory failure, Pediatrics 110:529, 2002.

186. Hibbs AM, Walsh MC, Martin RJ, et al: One-year respiratory outcomes of preterm infants enrolled in the Nitric Oxide (to prevent) Chronic Lung Disease trial, J Pediatr 153:525, 2008.

187. Higgins RD, Bancalari E, Willinger M, et al: Executive summary of the workshop on oxygen in neonatal therapies: controversies and opportunities for research, Pediatrics 119:790, 2007.

188. Hofer N, Jank K, Resch E, et al: Meconium aspiration syn-drome—a 21 years’ experience from a tertiary care center and analysis of risk factors for predicting severity, Klin Pediatr 225:383, 2013.

642.e6 References

189. Hofmeyr GJ, Xu H: Amnioinfusion for meconium-stained liq-uor in labour, Cochrane Database Syst Rev 1:CD000014, 2010.

190. Holleman-Duray D, Kaupie D, Weiss MG: Heated humidi-fied high-flow nasal cannula: use and neonatal early extubation, J Perinatol 27:776, 2007.

190a. Hoo AF, Beardsmore CS, Castle RA, et al and the INNOVO Trial Collaborating Group: Respiratory function during infancy in survivors of the INNOVO trial, Pediatric Pulmonary 44:155, 2009.

191. Hoskote A, Castle R, Hoo A, et al: Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hy-pertension, Pediatr Pulmonol 43:224, 2008.

192. Hough JL, Flenady V, Johnson L, et al: Chest physiotherapy for reducing respiratory morbidity in infants requiring ventilatory support, Cochrane Database Syst Rev 3:CD006445, 2008.

193. Howlett A, Ohlsson A: Inositol for respiratory distress syndrome in preterm infants, Cochrane Database Syst Rev 3:CD000366, 2012.

194. Inder TE, Benders M: Postnatal steroids in the preterm infant—the good, the ugly, and the unknown, J Pediatr 162:667, 2013.

195. Ingimarsson J, Bjorklund L, Curstedt T, et al: Incomplete protec-tion by prophylactic surfactant against the added effects of large lung inflations at birth in immature lambs, Intensive Care Med 30:1446, 2004.

196. Jardine LA, Inglis GD, Davies MW: Strategies for the withdrawal of nasal continuous positive airway pressure (NCPAP) in pre-term infants, Cochrane Database Syst Rev 2:CD006979, 2011.

197. Jobe AH: Postnatal corticosteroids for bronchopulmonary dys-plasia, Clin Perinatol 36:177, 2009.

198. Jobe AH: The new bronchopulmonary dysplasia, Curr Opin Pedi-atr 23:167, 2011.

199. Johnson K, Scott SD, Fraser KD: Oxygen use for preterm infants: factors that may influence clinical decisions surrounding oxygen titration, Adv Neonatal Care 11:8, 2011.

200. Johnson PJ: Caffeine citrate therapy for apnea of prematurity, Neonatal Netw 30:408, 2011.

201. Joshi VH, Bhuta T: Rescue high frequency jet ventilation versus conventional ventilation for severe pulmonary dysfunction in preterm infants, Cochrane Database Syst Rev 1:CD000437, 2006.

202. Kahramaner Z, Erdemir A, Turkoglu E, et al: Unsynchronized nasal intermittent positive pressure versus nasal continuous posi-tive airway pressure in pretrm infants after extubation, J Matern Fetal Neonatal Med 27:926, 2014.

203. Kahveci H, Yilmaz O, Avsar U, et al: Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the new-born, Pediatr Pulmonol, January 14, 2014. E-pub ahead of print.

203a. Kaiser J, Gauss C, Williams D: Tracheal suctioning is associated with prolonged disturbances of cerebral hemodynamics in very low birth weight infants, J Perinatol 28:34, 2008.

204. Kalyn A, Blatz S, Feuerstake S, et al: Closed suctioning of in-tubated neonates maintains better physiologic stability: a rand-omized controlled trial, J Perinatol 23:218, 2003.

205. Kamath-Rayne BD, DeFranco EA, Marcotte MP: Antenatal steroids for treatment of fetal lung immaturity after 34 weeks gestation: an evaluation of neonatal outcomes, Obstet Gynecol 119:909, 2012.

206. Kanmaz HG, Erdeve O, Canpolat FE, et al: Surfactant admin-istration via thin catheter during spontaneous breathing: rand-omized controlled trial, Pediatrics 131:e502, 2013.

207. Karemaker R, Heijnen CJ, Veen S, et al: Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone, Pediatr Res 60:745, 2006.

208. Karen T, Vatlatch S, Poets A, et al: The impact of oral sucrose on apnea and bradycardia in preterm infants: a randomized cross-over trial, Arch Dis Child Fetal Neonatal Ed 98:F93, 2012.

209. Karn CM, Steward DK: Nutrition and weight gain before the diagnosis of bronchopulmonary dysplasia, Newborn Infant Nurs Rev 5:149, 2005.

210. Kassab M, Khriesat WM, Bawadi H, Anabrees J: Furosemide for transient tachypnea of the newborn, Cochrane Database Syst Rev 6:CD003064, 2013.

211. Kattwinkel J: Endotracheal intubation. In Kattwinkel J, editor: Neonatal resuscitation provider textbook, ed 6, Elk Grove, Ill, 2011, American Academy of Pediatrics and American Heart Associa-tion.

212. Kavvadia V, Greenough A, Itakura Y, et al: Neonatal lung func-tion in very immature infants with and without RDS, J Perinat Med 27:382, 1999.

213. Kawaza K, Machen HE, Brown J, et al: Efficacy of a low-cost bubble CPAP system in treatment of respiratory distress in a neonatal ward in Malawi, PLoS One 9:e86327, 2014.

214. Keles E, Yazgan H, Gebesce A, Pahir E: The type of anesthesia used during cesarean section is related to the transient tachypnea of the newborn, ISRN Pediatr 2013:264340, 2013.

215. Kersbergen KJ, DeVries LS, Van Kooij BJ, et al: Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants, J Pediatr 163:666, 2013.

216. Keszler M: Strategy matters, Am J Perinatol 24:147, 2007. 217. Khalof N, Brodsky N, Hurley J, et al: A prospective randomized,

controlled trial comparing synchronized nasal intermittent posi-tive pressure ventilation vs. nasal continuous positive airway pres-sure as modes of extubation, Pediatrics 108:13, 2001.

218. Kieler H, Artama M, Engeland A, et al: Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries, BMJ 344:d8012, 2011.

219. Kiernan EA, Twomey AR, Molloy EJ, et al: Randomized trial of prongs or mask for nasal continuous positive airway pressure in preterm infants, Pediatrics 130:e1170, 2012.

220. Kim MJ, Yoo JH, Jung JA, Byun SY: The effects of inhaled al-buterol in transient tachypnea of the newborn, Allergy Asthma Immunol Res 6:126, 2014.

221. Kinsella J: Inhaled nitric oxide in the term newborn, Early Hum Dev 84:709, 2008.

222. Kinsella J, Cutter G, Walsh W, et al: Early inhaled nitric oxide therapy in premature newborns with respiratory failure, N Engl J Med 355:354, 2006.

223. Kiraly NJ, Tingay DG, Mills JF, et al: Volume not guaranteed: closed endotracheal suction compromises ventilation in volume-targeted mode, Neonatology 99:78, 2011.

224. Kirpalani H, Millar D, Lemyre B, and the NIPPV Study Group, et al: A trial comparing noninvasive ventilation strategies in pre-term infants, N Engl J Med 369:611, 2013.

225. Klebermass-Schrehof K, Wald M, Schwindt J, et al: Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity, Neonatology 103:252, 2013.

226. Klingberg C, Pettersen M, Hansen EA, et al: Patient comfort during treatment with heated humidified high flow nasal can-nulae versus nasal continuous positive airway pressure: a ran-domized cross-over trial, Arch Dis Child Fetal Neonatal Ed 99:F134, 2014.

227. Klinger G, Beyene J, Shah P, et al: Do hyperoxaemia and hy-pocapnia add to the risk of brain injury after intrapartum as-phyxia? Arch Dis Child Fetal Neonatal Ed 90:F49, 2005.

642.e7References

228. Knight D: Neonatal shaken baby syndrome: lessons to be learned, Arch Dis Child Fetal Neonatal Ed 87:F161, 2002.

229. Knight D, Bevan C, Harding J, et al: Chest physiotherapy and porencephalic lesions in very preterm infants, J Paediatr Child Health 37:554, 2001.

230. Kohelet D, Boaz M, Serour F, et al: Esophageal pH study and symptomatology of gastroesophageal reflux in newborn infants, Am J Perinatol 21:85, 2004.

231. Konduri GG, Sokol GM, Van Meurs KP, et al: Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure, J Perinatol 33:944, 2013.

232. Konduri GG, Vohr B, Robertson C, et al: Early inhaled nitric oxide therapy for term and near-term newborn infants with hy-poxic respiratory failure: neurodevelopmental follow-up, J Pediatr 150:235, 2007.

233. Koti J, Murki S, Gaddam P, et al: Bubble CPAP for respiratory distress syndrome in preterm infants, Indian Pediatr 47:139, 2010.

234. Kubicka ZJ, Limauro J, Darnall RA: Heated, humidified, high-flow nasal cannula therapy: yet another way to deliver continu-ous positive airway pressure? Pediatrics 121:82, 2008.

235. Kugelman A, Riskin A, Sais W, et al: A randomized pilot study com-paring heated humidified high-flow nasal cannulae with NIPPV for RDS, Pediatr Pulmonol, March 12, 2014. E-pub ahead of print.

236. Kumar P, and American Academy of Pediatrics, Committee on Fetus and Newborn: Use of inhaled nitric oxide in preterm in-fants, Pediatrics 133:164, 2014.

237. Kumar P, Denson SE, Mancuso TJ, and Committee on Fetus and Newborn, Section on Anesthesiology and Pain Medicine: Pre-medication for nonemergency endotracheal intubation, Pediatrics 125:608, 2010.

238. Kumar VH, Hutchison AA, Lakshminrusimha S, et al: Character-istics of pulmonary hypertension in preterm neonates, J Perinatol 27:214, 2007.

239. Kurzner SI, Garg M, Bautista DB, et al: Growth failure in infants with bronchopulmonary dysplasia: nutrition and elevated resting metabolic expenditure, Pediatrics 81:379, 1988.

240. Lal M, Manktelow B, Draper E, et al: Chronic lung disease of prematurity and intrauterine growth retardation: a population based study, Pediatrics 111:483, 2003.

241. Lampland AL, Plumm B, Meyers PA, et al: Observational study of humidified hogh-flow nasal cannula compared with nasal continuous positive airway pressure, J Pediatr 154:177, 2009.

242. Lazar DA, Cass DL, Olutoye OO, et al: The use of ECMO for persistent pulmonary hypertension of the newborn: a decade of experience, J Surg Res 177:263, 2012.

243. Leach CL, Greenspan JS, Rubenstein SD, et al: Partial liquid ventilation with perflubron in premature infants with severe res-piratory distress syndrome, N Engl J Med 335:761, 1996.

244. Lee BH, Stoll BJ, McDonald SA, et al: Adverse neonatal out-comes associated with antenatal dexamethasone versus antenatal betamethasone, Pediatrics 117:1503, 2006.

245. Lee J, Kim HS, Sohn JA, et al: Randomized crossover study of neutrally adjusted ventilator assist in preterm infants, J Pediatr 161:808, 2012.

246. Lemyre B, Davis P, DePaoli A: Nasal intermittent positive pres-sure ventilation (NIPPV) vs. nasal continuous positive airway pressure (NCPAP) for apnea of prematurity, Cochrane Database Syst Rev 1:CD002272, 2002.

247. Levesque BM, Kalisch LA, LaPierre J, et al: Impact of imple-menting 5 potentially better practices on neonatal outcomes and costs, Pediatrics 128:e218, 2011.

248. Liem JJ, Huq SI, Ekuma O, et al: Transient tachypnea of the newborn may be an early clinical manifestation of wheezing symptoms, J Pediatr 151:29, 2007.

248a. Lim D, Kulik T, Kim D, et al: Aminophylline for the prevention of apnea during prostaglandin E1 infusion, Pediatrics e27:112, 2003.

249. Lim K, Wheeler KI, Gale TJ, et al: Oxygen saturation targeting in preterm infants receiving continuous positive airway pressure, J Pediatr 164:730, 2014.

250. Lipkin P, Davidson D, Spivak L, et al: Neurodevelopmental and medical outcomes of PPHN in term newborns treated with ni-tric oxide, J Pediatr 140:306, 2002.

251. Lista G, Castoldi F, Bianchi S, et al: Volume guarantee versus high-frequency ventilation: lung inflammation in preterm in-fants, Arch Dis Child Fetal Neonatal Ed 93:F252, 2008.

252. Lista G, Castoldi F, Fontana P, et al: Nasal continuous positive airway pressure (CPAP) versus bi-level nasal CPAP in preterm babies with respiratory distress syndrome: a randomized con-trolled trial, Arch Dis Child Fetal Neonatal Ed 95:F85, 2010.

253. Liu J, Liu F, Liu Y, et al: Lung ultrasound for the diagnosis of severe neonatal pneumonia, Chest, May 15, 2014. E-pub ahead of print.

254. Livera L, Spencer S, Thorniley M, et al: Effects of hypoxaemia and bradycardia on neonatal cerebral haemodynamics, Arch Dis Child 66:376, 1991.

255. Locke R, Wolfson M, Shaffer T, et al: Inadvertent administration of positive end-distending pressure during nasal cannula flow, Pediatrics 91:135, 1993.

256. Machado LU, Fiori HH, Baldisserotto M, et al: Surfactant deficiency in transient tachypnea of the newborn, J Pediatr 159:750, 2011.

257. Manley BJ, Dold SK, Davis PG, Roehr CC: High-flow nasal cannulae for respiratory support of preterm infants: a review of the evidence, Neonatology 102:300, 2012.

258. Manley BJ, Owen LS, Doyle LW, et al: High-flow nasal cannulae in very preterm infants after extubation, N Engl J Med 369:1425, 2013.

259. Manzoni P, De Luca D, Stronati M, et al: Prevention of noso-comial infections in neonatal intensive care units, Am J Perinatol 30:81, 2013.

260. Mariani G, Cifuentes J, Carlo W: Randomized trial of permissive hypercapnia in preterm infants, Pediatrics 104:1082, 1999.

261. Marinelli P, Ortiz A, Alden E: Acquired eventration of the di-aphragm: a complication of chest tube placement in neonatal pneumothorax, Pediatrics 67:552, 1981.

262. McNamara PJ, Laique F, Muang-In S, et al: Milrinone improves oxygenation in neonates with severe persistent pulmonary hy-pertension of the newborn, J Crit Care 21:217, 2006.

263. McNamara PJ, Shivananda SP, Sahni M, et al: Pharmacology of milirinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide, Pediatr Crit Care Med 14:74, 2013.

264. Mercier JC, Hummler H, Durrmeyer X, and the EUNO Study Group, et al: Inhaled nitric oxide for prevention of bronchopul-monary dysplasia in premature babies (EUNO): a randomized controlled trial, Lancet 376:346, 2010.

265. Migliori C, Bottino R, Angeli A, et al: High frequency partial liquid ventilation in two infants, J Perinatol 24:118, 2004.

266. Mikolka P, Mokra D, Kopincova J, et al: Budesonide added to modified porcine surfactant improve the lung functions in meco-nium aspiration syndrome, Physiol Res 62(suppl):S191, 2013.

267. Miller JD, Carlo WA: Safety and effectiveness of permissive hypercapnia in the preterm infant, Curr Opin Pediatr 19:142, 2007.

642.e8 References

268. Mokra D, Calkovska A: How to overcome surfactant dysfunc-tion in meconium aspiration syndrome? Respir Physiol Neurobiol 187:58, 2013.

269. Mokra D, Mokry J, Tonhajzerova I: Anti-inflammatory treatment of meconium aspiration syndrome: benefits and risks, Respir Physiol Neurobiol 187:52, 2013.

270. Moretti C, Giannini L, Fassi C, et al: Nasal flow-synchronized intermittent positive pressure ventilation to facilitate weaning in very low-birthweight infants: unmasked randomized controlled trial, Pediatr Int 50:85, 2008.

271. Mori R, Kusuda S, Fujimura M: Antenatal corticosteroids pro-mote survival of extremely preterm infants born at 22-23 weeks gestation, J Pediatr 159:110, 2011.

272. Morley CJ, Davis PG, Doyle LW, et al: Nasal CPAP or intuba-tion at birth for very preterm infants, N Engl J Med 358:700, 2008.

273. Mosca F, Colnaghi M, Agosti M, Fumagalli M: High-flow nasal cannula: transient fashion or new method of non-invasive ven-tilator assistance? J Matern Fetal Neonatal Med 25(suppl 4):68, 2012.

274. Mosca F, Colnaghi M, Lattanzio M, et al: Closed versus open endotracheal suctioning in preterm infants: effects on cerebral oxygenation and blood volume, Biol Neonate 72:9, 1997.

275. Mourani PM, Sontag MK, Ivy DD, et al: Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease, J Pediatr 154:379, 2009.

276. Moya F, Gadzinowski J, Bancalari E, et al: A multicenter, ran-domized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory dis-tress syndrome among very preterm infants, Pediatrics 115:1018, 2005.

277. Mugford M, Elbourne D, Field D: Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants, Cochrane Database Syst Rev 3:CD001340, 2008.

278. Murphy KE, Willan AR, Hannah ME, et al: Effect of antenatal corticosteroids on fetal growth and gestational age at birth, Ob-stet Gynecol 119:917, 2012.

279. Nair J, Orie J, Lakshminrusimha S: Successful treatment of a neonate with idiopathic persistent pulmonary hypertension with inhaled nitric oxide via nasal cannula without mechanical venti-lation, AJP Rep 2:29, 2012.

280. Narandran V, Donovan E, Hoath S, et al: Early bubble CPAP and outcomes in ELBW preterm infants, J Perinatol 23:195, 2003.

281. National Institutes of Health: Antenatal corticosteroids revisited: repeat courses, NIH Consens Statement 2000(17):1, 2000.

282. Neonatal Inhaled Nitric Oxide Study Group: Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic res-piratory failure, N Engl J Med 336:597, 1997.

283. Neonatal Inhaled Nitric Oxide Study Group: Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the Neonatal Inhaled Nitric Oxide Study Group (NINOS), J Pediatr 136:611, 2000.

283a. Ng G, DaSilva O, Ohlsson A: Bronchodilators for the preven-tion and treatment of chronic lung disease in preterm infants, Cochrane Database Syst Rev 6:CD003214, 2012.

283b. Ng G, Ohlsson A: Cromolyn sodium for the prevention of chronic lung disease in preterm infants, Cochrane Database Syst Rev 6:CD003059, 2012.

284. Ng SP, Gomez JM, Lim SH, Ho NK: Reduction of nosocomial infection in a neonatal intensive care unit (NICU), Singapore Med J 39:319, 1998.

285. Niwas R, Nadroo AM, Sutija V, et al: Malposition of endotrache-al tube: association with pneumothorax in ventilated neonates, Arch Dis Child Fetal Neonatal Ed 92:F233, 2007.

286. Noori S, Friedlich P, Wong P, et al: Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension, Neonatology 91:92, 2007.

287. Noori S, McCoy M, Friedlich P, et al: Failure of ductus arte-riosus closure is associated with increased mortality in preterm infants, Pediatrics 123:e138, 2009.

288. Northway W, Rosan R: Radiographic features of pulmonary oxygen toxicity in the newborn: bronchopulmonary dysplasia, Radiology 91:49, 1968.

289. Nuntnarumit P, Bada H, Yang W, et al: Cerebral blood flow ve-locity changes after bovine natural surfactant instillation, J Peri-natol 4:240, 2000.

290. Nyp M, Sandritter T, Poppinga N, et al: Sildenafil citrate, bron-chopulmonary dysplasia and disordered pulmonary gas exchange: any benefits? J Perinatol 32:64, 2012.

291. Okasaki K, Kondo M, Kato M, et al: Serum cytokine and chemokine profiles in neonates with meconium aspiration syn-drome, Pediatrics 121:e748, 2008.

292. Onland W, Offringa M, Cools F, et al: Systemic Hydrocortisone to Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): a multicenter randomized placebo-controlled trial, BMC Pediatr 11:102, 2011.

293. Onland W, Offringa M, Van Kaam A: Late (>7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in pre-term infants, Cochrane Database Syst Rev 4:CD002311, 2012.

294. Ornoy A, Koren G: Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy, Sem-in Fetal Neonatal Med 19:188, 2014.

295. Padan ML, Conrad SA, Rycus PT, Thiagarajan RR, and the ELSO Registry: Extracorporeal life support Organization Reg-istry report 2012, ASAIOJ 59:202, 2013.

296. Panickar J, Scholefield H, Kumar Y, et al: Atypical chronic lung disease in preterm infants, J Perinat Med 32:162, 2004.

297. Parikh NA, Kennedy KA, Lasky RE, et al: Pilot randomized trial of hydrocortisone in ventilator-dependent extremely pretrm in-fants: effects on regional brain volumes, J Pediatr 162:685, 2013.

298. Patel DS, Rafferty GF, Lee S, et al: Work of breathing during SIMV with and without pressure support, Arch Dis Child 94:434, 2009.

299. Paula LC, Ceccon ME: Randomized, comparative analysis be-tween two tracheal suction systems in neonates, Rev Assoc Med Bras 56:434, 2010.

300. Peliowski: A, and the Canadian Paediatric Society, Fetus and Newborn Committee: Inhaled nitric oxide in newborns, Paediatr Child Health 17:95, 2012.

301. Pearlman J, Volpe J: Episodes of apnea and bradycardia in the pre-term newborn: impact on cerebral circulation, Pediatrics 76:33, 1985.

301a. Pearlman J, Volpe J: Suctioning on the preterm infant: effects on cerebral blood flow velocity, intracranial pressure, and arterial blood pressure, Pediatrics 72:329, 1983.

302. Peltoniemi O, Kari MA, Heinonen K, et al: Pre-treatment cortisol values may predict responses to hydrocortisone admin-istration for the prevention of bronchopulmonary dysplasia in high-risk infants, J Pediatr 146:632, 2005.

303. Peltoniemi OA, Lano A, Puosi R, and the Neonatal Hydrocor-tisone Working Group, et al: Trial of early neonatal hydrocorti-sone: two-year follow-up, Neonatology 95:240, 2009.

304. Peter C, Sporodowski N, Bohnhorst B, et al: Gastroesophageal re-flux and apnea of prematurity: no temporal relationship, Pediatrics 109:8, 2002.

642.e9References

305. Petty J: Understanding neonatal ventilation: strategies for deci-sion making in the NICU, Neonatal Netw 32:246, 2013.

306. Pfister RH, Soll RF, Wiswell T: Protein containing surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome, Cochrane Database Syst Rev 4:CD006180, 2009.

307. Pietrzyk JJ, Kwinta P, Wollen EJ, et al: Gene expression profiling in preterm infants: new aspects of bronchopulmonary dysplasia development, PLoS One 8:e78585, 2013.

308. Pillekamp F, Hermann C, Keller T, et al: Factors influencing ap-nea and bradycardia of prematurity: implications for neurodevel-opmental delay, Neonatology 91:155, 2007.

309. Pillow JJ, Minocchieri S: Innovation in surfactant therapy, II: sur-factant administration by aerosolization, Neonatology 101:337, 2012.

310. Piotrowski A, Sobala W, Kawczynski P: Patient initiated, pressure- regulated, volume-controlled ventilation compared with intermittent mandatory ventilation in neonates: a prospec-tive, randomized study, Intensive Care Med 23:975, 1997.

311. Pirr SM, Lange M, Hartmenn C, et al: Closed versus open en-dotracheal suctioning in extremely low-birth-weight neonates: a randomized, crossover trial, Neonatology 103:124, 2013.

312. Poets C: Gastroesophageal reflux: a critical review of its role in preterm infants, Pediatrics 113:128, 2004.

313. Poets CF: Interventions for apnoea of prematurity: a personal view, Acta Paediatr 99:172, 2010.

314. Poets CF: Gastroesophageal reflux and apnea of prematurity—coincidence, not causation, Neonatology 103:103, 2013.

315. Polin RA, Carlo WA, and Committee on Fetus and Newborn: Surfactant replacement therapy for preterm and trem neonates with respiratory distress, Pediatrics 133:156, 2014.

316. Porta NFM, Steinhorn RH: Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil and other pulmonary vasodilating agents, Clin Perinatol 39:149, 2012.

317. Porto AM, Coutinho IC, Correia JB, Amorim MM: Effectiveness of antenal corticosteroids in reducing respiratory disorders in late pretetrm infants: randomized clinical trial, BMJ 342:d1696, 2011.

317a. Powell K, Kerkering KW, Barker G, et al: Dexamethasone dos-ing, mechanical ventilation and the risk of cerebral palsy, J Ma-tern Fetal Neonatal Med 19:43, 2006.

318. Pritchard M, Flenady V, Woodgate P: Systematic review of the role of preoxygenation for tracheal suctioning in ventilated new-born infants, J Paediatr Child Health 39:163, 2003.

319. Purohit D, Caldwell C, Levkoff A: Multiple fractures due to physiotherapy in a neonate with hyaline membrane disease, Am J Dis Child 129:1103, 1975.

320. Rademaker KJ, deVries LS, Uiterwaal CS, et al: Postnatal hy-drocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up, Arch Dis Child Fetal Neonatal Ed 93:F58, 2008.

321. Rainer C, Gardetto A, Fruhwirth M, et al: Breast deformity in adolescence as a result of pneumothorax drainage during neona-tal intensive care, Pediatrics 111:80, 2003.

322. Ramaekers V, Casaer P, Daniels H: Cerebral hyperperfusion fol-lowing episodes of bradycardia in the preterm infant, Early Hum Dev 34:199, 1993.

323. Ramanathan R: Nasal respiratory support through the nares: its time has come, J Perinatol 30(suppl):S67, 2010.

324. Ramanathan R, Sekar KC, Rasmussen M, et al: Nasal intermit-tent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants < 30 weeks’ ges-tation: a randomized controlled trial, J Perinatol 32:336, 2012.

325. Ramsay S: The Birmingham experience, Lancet 345:510, 1995.

326. Raval D, Yeh T, Mora A, et al: Chest physiotherapy in preterm in-fants with RDS in the first 24 hours of life, J Perinatol 7:301, 1987.

327. Redline R, Wilson-Costello D, Hack M: Placental and other perinatal risk factors for chronic lung disease in very low birth-weight infants, Pediatr Res 52:713, 2002.

328. Reyes ZC, Claure N, Tauscher MK, et al: Randomized, controlled trial comparing synchronized intermittent mandatory ventilation and synchronized intermittent mandatory ventilation plus pres-sure support in preterm infants, Pediatrics 118:1409, 2006.

329. Rhein LM, Dobson NR, Darnall RA, and the Caffeine Pilot Study Group, et al: Effects of caffeine on intermittent hypoxia in infants born prematurely: a randomized controlled trial, JAMA Pediatr 168:250, 2014.

330. Ricotti A, Salvo V, Zimmerman LJ, et al: N-SIPPV versus bi-level N-CPAP for early treatment of respiratory distress syndrome in preterm infants, J Matern Fetal Neonatal Med 26:1346, 2013.

331. Rieger H, Kuhle S, Ipsiroglu OS, et al: Effects of open vs. closed system endotracheal suctioning on cerebral blood flow velocities in mechanically ventilated extremely low birth weight infants, J Perinatol Med 33:435, 2005.

332. Roberts CT, Dawson JA, Alquoka E, et al: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants?, Arch Dis Child Fetal Neonatal Ed, March 13, 2014. E-pub ahead of print.

333. Roberts D, Dalziel S: Antenatal corticosteroids for accelerat-ing fetal lung maturation for women at risk of preterm birth, Cochrane Database Syst Rev 3:CD004454, 2006.

334. Rogers E, Alderdice F, McCall E, et al: Reducing nososcomial infections in neonatal intensive care, J Matern Fetal Neonatal Med 23:1039, 2010.

335. Rojas MA, Lozano JM, Rojas MX, and the Colombian Neonatal Research Network, et al: Very early surfactant without mandato-ry ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial, Pediatrics 123:137, 2009.

336. Rojas-Reyes MX, Morley CJ, Soll R: Prophylactic versus selec-tive use of surfactant in preventing morbidity and mortality in preterm infants, Cochrane Database Syst Rev 3:CD000510, 2012.

337. Romejko-Wolniewicz E, Teliga-Czajkowska J, Czaajkowski K: Antenatal steroids: can we optimize the dose? Curr Obstet Gy-necol 26:77, 2014.

338. Romero R, Yoon BH, Chaemsaithong P, et al: Secreted phos-pholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meco-nium aspiration syndrome, J Matern Fetal Neonatal Med, January 6, 2014. E-pub ahead of print.

339. Rosenthal VD, Rodriguez-Calderon ME, Rodriguez-Ferrer M, et al: Findings of the International Nosocomial Control Con-sortium (INICC), part II: impact of a multidimensional strategy to reduce ventilator-associated pneumonia in neonatal intensive care units in 10 developing countries, Infect Control Hosp Epide-miol 33:704, 2012.

340. Rushton D: Neonatal shaken baby syndrome: historical inexacti-tudes, Arch Dis Child Fetal Neonatal Ed 87:F161, 2003.

341. Ryu J, Haddad G, Carlo WA: Clinical effectiveness and safety of permissive hypercapnia, Clin Perinatol 39:603, 2012.

342. Salama H, Abughalwa M, Taha S, et al: Transient tachypnea of the newborn: is empiric antimicrobial therapy needed? J Neonatal Perinatal Med 6:237, 2013.

343. Salvesen B, Curstedt T, Mollnes TE, Saugstad OD: Effects of nat-ural versus synthetic surfactant with SP-B and SP-C analogs in a porcine model of meconium aspiration syndrome, Neonatology 105:128, 2014.

642.e10 References

344. Sandri F, Ancora G, Lanzoni A, et al: Prophylactic nasal continu-ous positive airways pressure in newborns of 28-31 weeks, gesta-tion: multicenter randomized controlled clinical trial, Arch Dis Child Fetal Neonatal Ed 89:F394, 2004.

345. Sarkar S, Hussain N, Herson V: Fibrin glue for persistent pneu-mothorax in neonates, J Perinatol 23:82, 2003.

346. Saslow JG, Agahi ZH, Nakhla TA, et al: Work of breathing using high-flow nasal cannulae in preterm infants, J Perinatol 26:476, 2006.

347. Saugstad O: Oxygen radical disease in neonatology, Biol Neonate 88:228, 2005.

348. Saugstad OD, Aune D: In search of the optimal oxygen satura-tion for extremely low birth weight infants: a systematic review and meta-analysis, Neonatology 100:1, 2011.

349. Saugstad OD, Aune D: Optimal oxygenation of extremely low birth weight infants: a meta-analysis and systematic review of the oxygen saturation target studies, Neonatology 105:55, 2014.

350. Saugstad OD, Kwinta P, Wollen EJ, et al: Impact of antenatal glucocorticosteroids on whole-genome expression in preterm babies, Acta Paediatr 102:349, 2013.

351. Schipper J, Mohammad G, van Straaten H, et al: The impact of surfactant replacement therapy on cerebral and systemic circula-tion and lung function, Eur J Pediatr 156:224, 1997.

352. Schmidt B, Roberts RS, Davis P, for the Caffeine for Apnea of Prematurity Trial Group, et al: Caffeine therapy for apnea of prematurity, N Engl J Med 354:2112, 2006.

353. Schmidt B, Roberts RS, Davis P, et al: Long-term effects of caffeine therapy for apnea of prematurity, N Engl J Med 357:1893, 2007.

354. Schmidt B, Whyte RK, Asztalos EV, and the Canadian Oxygen Trial (COT) group, et al: Effects of targeting higher vs. lower arterial oxygen saturations on death or disability in extreme-ly preterm infants: a randomized clinical trial, J Am Med Assoc 309:2111, 2013.

355. Schreiber M, Gin-Mestan K, Narks J, et al: Inhaled NO in pre-mature infants with RDS, N Engl J Med 349:2099, 2003.

356. Schulze A, Gerhardt T, Musante G, et al: Proportional assist ven-tilation in low birth weight infants with acute respiratory dis-ease: a comparison to assist/control and conventional mechanical ventilation, J Pediatr 135:339, 1999.

357. Schulze A, Rieger-Fackeldey E, Gerhardt T, et al: Randomized crossover comparison of proportional assist ventilation and patient- triggered ventilation in extremely low birth weight in-fants with evolving chronic lung disease, Neonatology 92:1, 2007.

358. Seidner SR, Ikegami M, Yamada T, et al: Decreased surfactant dose-response after delayed administration to preterm rabbits, Am J Respir Crit Care Med 152:113, 1995.

359. Shah P, Ohlsson A: Sildenafil for pulmonary hypertension in neonates, Cochrane Database Syst Rev 3:CD005494, 2007.

360. Deleted in pages. 361. Shah SS, Ohlsson A, Halliday H, Shah VS: Inhaled versus sys-

temic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants, Cochrane Data-base Syst Rev 5:CD002057, 2012.

362. Shah SS, Ohlsson A, Halliday H, ShahVS: Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm infants, Cochrane Database Syst Rev 5:CD002058, 2012.

363. Shah VS, Ohlsson A, Halliday H, Dunn M: Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates, Cochrane Da-tabase Syst Rev 5:CD001969, 2012.

364. Shenai J: Vitamin A supplementation in VLBW neonates: ration-ale and evidence, Pediatrics 104:1369, 1999.

365. Shenai J, Mellen B, Chytil F: Vitamin A status and postnatal dexa-methasone treatment in BPD, Pediatrics 106:547, 2000.

366. Shi Y, Tang S, Zhao J, Shen J: A prospective, randomized, controlled study of NIPPV versus nCPAP in preterm and term infants with respiratory distress syndrome, Pediatr Pulmonol, September 4, 2013. E-pub ahead of print.

367. Shoemaker MT, Pierce MR, Yoder BA, et al: High flow nasal cannula versus nasal CPAP for neonatal respiratory disease: a ret-rospective study, J Perinatol 27:85, 2007.

368. Singh N, Hawley KL, Viswanathan K: Efficacy of porcine versus bovine surfactants for pretrem newborns with respiratory dis-tress syndrome: systematic review and meta-analysis, Pediatrics 128:e1588, 2011.

369. Simoes E, Rosenberg A, King S, et al: Room air challenge: pre-diction for successful weaning of oxygen dependent infants, J Perinatol 17:125, 1997.

370. Singh SN, Malik GK, Prashanth GP, et al: High frequency venti-lation versus synchronized intermittent mandatory ventilation in preterm neonates with hyaline membrane disease: a randomized controlled trial, Indian Pediatr 49:405, 2012.

371. Singh SN, Srivastava R, Singh A, et al: Respiratory distress in-cluding meconium aspiration syndrome in vigorous neonates born through meconium stained amniotic fluid: incidence, onset, severity and predictors at birth, Indian J Pediatr 80:538, 2013.

372. Slocum C, Arko M, DiFiore J, et al: Apnea, bradycardia and de-saturation in preterm infants before and after feeding, J Perinatol 29:209, 2009.

373. Sola A: Oxygen for the preterm newborn: one infant at a time, Pediatrics 121:1257, 2008.

374. Soll R: Multiple versus single doses of exogenous surfactant ex-tract for the prevention or treatment of neonatal respiratory dis-tress syndrome, Cochrane Database Syst Rev 1:CD000141, 2009.

375. Soll RF: Commentary on elective high-frequency oscillatory ventilation versus conventional mechanical ventilation for acute pulmonary dysfunction in preterm infants, Neonatology 103:8, 2013.

376. Speer CP, Sweet DG: Surfactant replacement: present and future. In Bancalari E, editor: The newborn lung, ed 2, Philadelphia, 2012, Elsevier.

376a. Squires AJ, Hyndman M: Prevention of nasal injuries second-ary to NCPAP application in the ELBW infant, Neonatal Netw 28:13, 2009.

377. Squires KA, DePaoli AG, Williams C, Dargaville PA: High- frequency oscillatory ventilation with low oscillatory frequency in pulmonary interstitial emphysema, Neonatology 104:243, 2013.

378. Sreenan C, Lemke R, Hudson-Mason A, et al: High-flow nasal cannulae in the management of apnea of prematurity: a compar-ison with conventional nasal continuous positive airway pressure, Pediatrics 107:1081, 2001.

379. Sriram S, Wall S, Khoshnood B, et al: Racial disparity in meco-nium-stained amniotic fluid and meconium aspiration syndrome in the United States, 1989-2000, Obstet Gynecol 102:1262, 2003.

380. Stark AR, Carlo WA, Tyson JE, et al: Adverse effects of early dex-amethasone treatment in extremely low-birth-weight infants, N Engl J Med 344:95, 2001.

381. Stefanescu B, Murphy W, Hansell B, et al: A randomized, con-trolled trial comparing two different continuous positive airway pressure systems for the successful extubation of ELBW infants, Pediatrics 112:1031, 2003.

642.e11References

382. Stein H, Alosh H, Ethington P, White DB: Prospective cross-over comparison between NAVA and pressure control venti-lation in premature neonates less than 1500 grams, J Perinatol 33:452, 2013.

383. Steinhorn RH: Pharmacotherapy of pulmonary hypertension, Pediatr Clin North Am 59:1129, 2012.

384. Steinhorn RH: Diagnosis and treatment of pulmonary hyper-tension in infancy, Early Hum Dev 89:865, 2013.

385. Steinhorn RH, Kinsella JP, Pierce C, et al: Intravenous sildenafil in the treatment of neonates with persistent pulmonary hyper-tension, J Pediatr 155:841, 2009.

386. Stern L: Therapy of the respiratory distress syndrome, Pediatr Clin North Am 19:221, 1972.

387. Stevens T, Blennow M, Soll R: Early surfactant administration with brief ventilation vs selective surfactant and continued me-chanical ventilation for preterm infants with or at risk for respira-tory distress syndrome, Cochrane Database Syst Rev 4:CD003063, 2007.

388. Stewart A, Brion LP: Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease, Cochrane Database Syst Rev 9:CD001453, 2011.

389. Stewart A, Brion LP, Ambrosio-Perez I: Diuretics acting on the distal renal tubule for preterm infants with (or developing) chron-ic lung disease, Cochrane Database Syst Rev 9:CD001817, 2011.

390. Stoll B, Hansen N, Fanaroff A, et al: Late-onset sepsis in VLBW neonates: the experience of the NICHD Neonatal Research Network, Pediatrics 110:285, 2002.

391. Stroustrup A, Transande L, Holzman IR: Randomized controlled trial of restrictive fluid management in transient tachypnea of the newborn, J Pediatr 160:38, 2012.

392. Sun B: Inhaled nitric oxide and neonatal brain damage: experi-mental and clinical evidences, J Matern Fetal Neonatal Med 25:51, 2013.

393. Sun H, Chang R, Kang W, et al: High-frequency oscillatory ven-tilation versus synchronized intermittent mandatory ventilation plus pressure support in preterm infants with severe respiratory distress syndrome, Respir Care 59:159, 2014.

394. SUPPORT study group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Carlo WA, Finer NN, et al: Target ranges of oxygen saturation in extremely preterm infants, N Engl J Med 362:1959, 2010.

395. Swarnam K, Soraisham AS, Sivanandan S: Advances in the management of meconium aspiration syndrome, Int J Pediatr 2012:359571, 2012.

396. Sweet DG, Carnielli V, Greisen G, et al: European consensus guidelines on the management of neonatal respiratory dis-tress syndrome in preterm infants—2013 update, Neonatology 103:353, 2013.

397. Szymankiewicz M, Vidyasagar D, Gadzinowski J: Predictors of successful extubation or preterm low-birth-weight infants with respiratory distress syndrome, Pediatr Crit Care Med 6:44, 2005.

398. Tam EW, Chau V, Ferriero DM, et al: Preterm cerebellar growth impairment after postnatal exposure to glucocorticosteroids, Sci Transl Med 3:105ra105, 2011.

399. Tan B, Zhang F, Ahang X, et al: Risk factors for ventilator-as-sociated pneumonia in the neonatal intensive care unit: a meta-analysis of observational studies, Eur J Pediatr 173:427, 2014.

400. Tang S, Zhao J, Shen J, et al: Nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure in neonates: a systematic review and meta-analysis, Indian Pediatr 50:371, 2013.

401. Tanriverdi S, Koroglu OA, Uygur O, et al: The effect of inhaled nitric oxide therapy on thromboelastogram in newborns with persistent pulmonary hypertension, Eur J Pediatr, May 4, 2014. E-pub ahead of print.

402. Tapia JL, Urzua S, Bancalari A, and the South American Neoco-sur Network, et al: Randomized trial of early bubble continu-ous positive airway pressure for very low birth weight infants, J Pediatr 161:75, 2012.

403. Taylor JE, Hawley G, Flenady V, Woodgate PG: Tracheal suc-tioning without disconnection in intubated ventilated neonates, Cochrane Database Syst Rev 2:CD003065, 2011.

404. Ter Wolbeek M, de Sonneville LM, de Vries WB, et al: Early life intervention with glucocorticoids has negative effects on motor development and neuropsychological function in 14-17 year-old adolescents, Psychoneuroendocrinology 38:975, 2013.

405. The STOP-ROP Multicenter Study Group: Supplemental therapeutic oxygen for pre-threshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial, I: primary out-comes, Pediatrics 105:295, 2000.

406. Thomas NJ, Guardia CG, Moya FR, and the PALISI Network, et al: A pilot, randomized, controlled clinical trial of lucinactant, a peptide-containing synthetic surfactant, in infants with acute hy-poxemic respiratory failure, Pediatr Crit Care Med 13:646, 2012.

407. Tin W, Gupta S: Optimum oxygen therapy in preterm babies, Arch Dis Child Fetal Neonatal Ed 92:F143, 2005.

408. Tin W, Milligan W, Pennefather P, et al: Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks’ gestation, Arch Dis Child Fetal Neonatal Ed 84:F106, 2001.

409. Tin W, Wiswell T: Adjunctive therapies in chronic lung disease: examining the evidence, Semin Fetal Neonatal Med 13:44, 2008.

409a. Torres C, Holditch-Davis D,O’Hale A, et al: Effect of standard rest periods on apnea and weight gain in preterm infants, Neona-tal Netw 16:35, 1997.

410. Tourneux P, Cardot V, Museaux N, et al: Influence of ther-mal drive on central sleep apnea in the preterm neonate, Sleep 31:549, 2008.

411. Tourneux P, Rakza T, Bouissou A, et al: Pulmonary circulatory effects of norepinephrine in newborn infants with persistent pulmonary hypertension, J Pediatr 153:345, 2008.

412. Tran S, Caughey A, Musci T: Meconium-stained amniotic flu-id is associated with puerperal infections, Am J Obstet Gynecol 189:746, 2003.

413. Truog WE, Ballard PL, Norberg M, and the Nitric Oxide (to Prevent) Chronic Lung Disease Study Investigators, et al: In-flammatory markers and mediators in tracheal fluid of prema-ture infants treated with inhaled nitric oxide, Pediatrics 119:670, 2007.

414. Tsao P, Wei S, Su Y, et al: Placenta growth factor elevation in the cord blood of premature neonates predicts poor pulmonary outcome, Pediatrics 113:1348, 2004.

415. Tuncer O, Peker E, Demir N, et al: Spectrophotometric analy-sis in umbilical cords of infants with meconium aspiration syn-drome, J Membr Biol 246:525, 2013.

416. Turunen R, Nupponen I, Siitonen S, et al: Onset of mechani-cal ventilation is associated with rapid activation of circulating phagocytes in preterm infants, Pediatrics 117:448, 2006.

417. Van Berkel S, Binkhorst M, Van Heijst AF, et al: Adapted ECMO criteria for newborns with persistent pulmonary hypertension after inhaled nitric oxide and/or high-frequency oscillatory ven-tilation, Intensive Care Med 39:1113, 2013.

642.e12 References

418. Vain N, Szyld E, Prudent L, et al: Oropharyngeal and naso-pharyngeal suctioning of meconium-stained neonates before delivery of their shoulders: multicenter, randomized controlled trial, Lancet 364:597, 2004.

419. Vanderveen DK, Mansfield TA, Eichenwald EC: Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity, JAAPOS 10:445, 2006.

420. Velaphi S, Vidayasagar D: Intrapartum and postdelivery man-agement of infants born to mothers with meconium-stained amniotic fluid: evidence-based recommendations, Clin Perinatol 33:29, 2006.

421. Vento G, Tana M, Tirone C, et al: Efficacy of exogenous surfactant during conventional and high-frequency oscillatory ventilation in preterm infants with RDS, Acta Biomed 84(suppl 1):25, 2013.

422. Vergales BD, Paget-Brown AO, Lee H, et al: Accurate automat-ed apnea analysis in preterm infants, Am J Perinatol 31:157, 2014.

423. Vergine M, Copetti R, Brusa G, Cattarossi L: Lung ultrasound accuracy in respiratory distress syndrome and transient tachypnea of the newborn, Neonatology 106:87, 2014.

424. Wapner RJ, Sorokin Y, Mele L, for the National Institutes of Child Health and Human Development Maternal-Fetal Medi-cine Units Network, et al: Long-term outcomes after repeat doses of antenatal corticosteroids, N Engl J Med 357:1190, 2007.

425. Ward-Larson C, Horn R, Gosnell F: The efficacy of facilitated tucking for relieving procedural pain of endotracheal suctioning in very low birthweight infants, MCN Am J Matern Child Nurs 29:151, 2004.

426. Wardle AJ, Wardle R, Luyt K, Tulloh R: The utility of sidenafil in pulmonary hypertension: a focus on bronchopulmomary dyspla-sia, Arch Dis Child 98:613, 2013.

427. Wardle S, Hughes A, Chen S, et al: Randomized controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease, Arch Dis Child Fetal Neonatal Ed 84:F9, 2001.

428. Watterberg K, Gerdes J, Cole C, et al: Prophylaxis of early ad-renal insufficiency to prevent BPD: a multicenter trial, Pediatrics 114:1649, 2004.

429. Watterberg K, Gerdes J, Gifford KL, Lin HM: Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in pre-mature infants, Pediatrics 104:1258, 1999.

430. Watterberg KL, Shaffer ML, Mishefske MJ, et al: Growth and neurodevelopmental outcomes after early low-dose hydrocorti-sone treatment in extremely low birth weight infants, Pediatrics 120:40, 2007.

431. Weintraub AS, Cadet CT, Perez R, et al: Antibiotic use in new-borns with transient tachypnea of the newborn, Neonatology 103:235, 2013.

432. Wheeler K, Klingenberg C, McCallion N, et al: Volume-guaran-tee versus pressure-limited ventilation in the neonate, Cochrane Database Syst Rev 11:CD003666, 2010.

433. Wheeler K, Morley CJ, Hooper SB, Davis PG: Lower back-up rates improve ventilator triggering during assist-control ventila-tion: a randomized crossover trial, J Perinatol 32:111, 2012.

434. Wiedemann JR, Saugstad AM, Barnes-Powell L, et al: Meco-nium aspiration syndrome, Neonatal Netw 27:81, 2008.

435. Wilkinson D, Andersen C, O’Donnell CP, De Paoli AG: High flow nasal cannula for respiratory support in preterm infants, Cochrane Database Syst Rev 11:CD006405, 2011.

436. Wilkinson D, Andersen C, Smith K, et al: Pharyngeal pressure with high-flow nasal cannulae in premature infants, J Perinatol 28:42, 2008.

437. Williams A, Sunderland R: Neonatal shaken baby syndrome: an aetiological view from Down Under, Arch Dis Child Fetal Neo-natal Ed 86:F29, 2002.

438. Williams PD, Press A, Williams AR, et al: Fatigue in mothers of infants discharged to the home on apnea monitors, Appl Nurs Res 12:69, 1999.

439. Wilson G, Hughes G, Rennie J, et al: Evaluation of two endotra-cheal suction regimes in babies ventilated for respiratory distress syndrome, Early Hum Dev 25:87, 1991.

440. Wilson-Costello D, Walsh MC, Langer JC, et al: Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months’ adjusted age: effects of dose, timing, and risk of bron-chopulmonary dysplasia in extremely low birth weight infants, Pediatrics 123:e430, 2009.

441. Wood B: Infant ribs: generalized periosteal reaction resulting from vibrator chest physiotherapy, Radiology 162:811, 1987.

442. Woodgate P, Flenady V: Tracheal suctioning without disconnec-tion in intubated ventilated neonates, Cochrane Database Syst Rev 12:CD003065, 2011.

443. Wrightson D: Suctioning smarter: answers to eight common questions about endotracheal suctioning in neonates, Neonatal Netw 18:51, 1999.

444. Wu CS, Lee CM, Yuh YS, Hua YM: Influence of changing the diameter of the bubble generator bottle and expiratory limb on bubble CPAP: an in vitro study, Pediatr Neonatol 53:359, 2012.

445. Yagui AC, Vale LA, Haddad LB, et al: Bubble CPAP versus CPAP with variable flow in newborns with respiratory distress: a rand-omized controlled trial, J Pediatr (Rio J) 87:499, 2011.

446. Yoder BA, Stoddard RA, Li M, et al: Heated, humidified high-flow cannula versus nasal CPAP for respiratory support in neo-nates, Pediatrics 11:e1482, 2013.

447. York J, Landers S, Kirby R, et al: Arterial oxygen fluctuation and ROP in VLBW infants, J Perinatol 24:82, 2004.

448. Youngquist TM, Richardson CP, Diblasi RM: Effects of con-densation in the exhalation limb of neonatal circuits on airway pressure during bubble CPAP, Respir Care 58:1840, 2013.

449. Yuksel B, Greenough A, Gamsu H: Neonatal MAS and respira-tory morbidity during infancy, Pediatr Pulmonol 16:358, 1993.

450. Zanardo V, Freato F: Home oxygen therapy in infants with bron-chopulmonary dysplasia: assessment of parental anxiety, Early Hum Dev 65:39, 2001.

451. Zhou Q, Leew SK, Jiang SY, et al: Efficacy of an infection control program in reducing ventilator-associated pneumonia in a Chinese neonatal intensive care unit, Am J Infect Control 41:1059, 2013.

RESOURCE MATERIALS FOR PROFESSIONALS AND PARENTSBissinger R, Mancinelli JP, Shirland L: High-frequency jet and oscillator

ventilation: resource guide, Chicago, 2013, National Association of Neonatal Nurses.

Bonner KM, Mainous RO: The nursing care of the infant receiving bubble CPAP therapy, Adv Neonatal Care 8:78, 2008.

Brown MK, DiBlasi RM: Mechanical ventilation of the premature neonate, Respir Care 56:1298, 2011.

Fiske E: Effective strategies to prepare infants and families for home tracheostomy care, Adv Neonatal Care 4:42, 2004.

Fiske E: Tracheostomy home care guide, Adv Neonatal Care 4:54, 2004.Gracey K, Talbot D, Lankford R, et al: The changing face of BPD.

II. Discharging an infant home on oxygen, Adv Neonatal Care 3:88, 2003.

642.e13References

Gracey K, Talbot D, Lankford R, et al: Nasal cannula home oxygen, Adv Neonatal Care 3:99, 2003.

Greenough A, Bhat P: How to ventilate term babies, Early Hum Dev 88:921, 2012.

INO: Therapeutics: Helping baby breathe: treating newborns with respira-tory problems, Canada, 2005, The Stay Well Company.

Petty J: Understanding neonatal ventilation: strategies for decision making in the NICU, Neonatal Netw 32:246, 2013.

Sant’Anna GM, Keszler M: Developing a neonatal unit ventilation protocol for the preterm baby, Early Hum Dev 88:925, 2012.

Stokowski LA: A primer on apnea of prematurity, Adv Neonatal Care 5:155, 2005.

Stokowski LA: Family Teaching Toolbox: a parents’ guide to under-standing apnea, Adv Neonatal Care 5:175, 2005.